ARVEE

Arvee Laboratories (India) Limited

Chemicals manufacturer with textile and non-textile segments

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

arveelabs.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹226.20
Market cap
249 Cr
Stock P/E
61.4
P/B
7.38
ROE (FY26)
7.5%
ROCE (FY26)
7.6%
Operating margin (FY26)
6.3%
Debt / equity (FY26)
0.03
OCF / EBITDA (FY26)
-3.7%
OCF / EBITDA (3Y)
66.8%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Arvee Laboratories is an Ahmedabad-based chemicals manufacturer with a textile chemical business (films and fibre) and a larger non-textile chemicals business.

Company snapshot

58thBy market cap

Ranked among 68 companies in Specialty Chemicals.

What we see

Positives
  • ✓Debt-to-equity of 0.03x — the company is largely funded by its own money, not borrowed funds.

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales8 Cr8 Cr6 Cr11 Cr13 Cr9 Cr6 Cr7 Cr3 Cr10 Cr11 Cr17 Cr
Operating expenses (approx.)7 Cr7 Cr5 Cr9 Cr11 Cr9 Cr6 Cr7 Cr3 Cr8 Cr10 Cr15 Cr
EBITDA0.98 Cr0.52 Cr0.80 Cr2 Cr2 Cr0.35 Cr0.22 Cr0.34 Cr0.13 Cr2 Cr1 Cr2 Cr
OPM %13.0%6.8%13.0%14.5%12.0%3.9%3.5%4.6%3.7%16.6%10.2%14.5%
Other income0.09 Cr0.19 Cr0.21 Cr0.11 Cr0.16 Cr0.19 Cr0.21 Cr0.17 Cr0.23 Cr0.14 Cr0.15 Cr0.18 Cr
Interest0.07 Cr0.05 Cr0.05 Cr0.08 Cr0.05 Cr0.05 Cr0.07 Cr0.04 Cr0.04 Cr0.07 Cr0.08 Cr0.06 Cr
Depreciation0.35 Cr0.35 Cr0.37 Cr0.31 Cr0.30 Cr0.28 Cr0.27 Cr0.29 Cr0.30 Cr0.30 Cr0.31 Cr0.32 Cr
Profit before tax0.65 Cr0.32 Cr0.58 Cr1 Cr1 Cr0.21 Cr0.09 Cr0.17 Cr0.01 Cr1 Cr0.85 Cr2 Cr
Tax %25.2%25.2%79.9%25.2%25.2%25.1%26.3%2.9%1.9%-31.2%39.1%26.0%
Net profit0.49 Cr0.24 Cr0.12 Cr0.94 Cr0.98 Cr0.15 Cr0.07 Cr0.17 Cr0.01 Cr2 Cr0.52 Cr2 Cr
EPS (₹)₹0.44₹0.22₹0.11₹0.85₹0.89₹0.14₹0.06₹0.15₹0.01₹1.66₹0.47₹1.54

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales34 Cr47 Cr40 Cr62 Cr30 Cr38 Cr32 CrSign in free for the trailing twelve months
Operating expenses (approx.)29 Cr41 Cr35 Cr54 Cr27 Cr35 Cr28 CrSign in free for the trailing twelve months
EBITDA6 Cr6 Cr6 Cr8 Cr3 Cr4 Cr3 CrSign in free for the trailing twelve months
OPM %17.1%12.7%14.0%13.5%9.9%9.4%10.1%Sign in free for the trailing twelve months
Other income0.51 Cr0.58 Cr0.46 Cr0.22 Cr0.58 Cr0.66 Cr0.68 CrSign in free for the trailing twelve months
Interest3 Cr0.58 Cr0.36 Cr0.39 Cr0.25 Cr0.25 Cr0.23 CrSign in free for the trailing twelve months
Depreciation2 Cr2 Cr2 Cr2 Cr1 Cr1 Cr1 CrSign in free for the trailing twelve months
Profit before tax0.86 Cr4 Cr3 Cr6 Cr2 Cr3 Cr2 CrSign in free for the trailing twelve months
Tax %-80.4%26.5%25.4%33.2%42.5%25.2%-3.9%Sign in free for the trailing twelve months
Net profit2 Cr3 Cr3 Cr4 Cr1 Cr2 Cr3 CrSign in free for the trailing twelve months
EPS (₹)₹3.83₹2.43₹2.34₹3.74₹0.95₹1.95₹2.29Sign in free for the trailing twelve months
Dividend payout %—0.0%0.0%0.0%0.0%0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital4 Cr11 Cr11 Cr11 Cr11 Cr11 Cr11 Cr
Reserves0.14 Cr10 Cr13 Cr17 Cr18 Cr20 Cr23 Cr
Borrowings24 Cr9 Cr3 Cr1 Cr1 Cr1 Cr1 Cr
Other liabilities8 Cr11 Cr12 Cr10 Cr8 Cr6 Cr8 Cr
Total liabilities36 Cr41 Cr39 Cr39 Cr39 Cr38 Cr43 Cr
Fixed assets (net)17 Cr14 Cr14 Cr13 Cr13 Cr15 Cr17 Cr
CWIP—0.97 Cr0.98 Cr2 Cr3 Cr0.73 Cr0.90 Cr
Investments—2 Cr—0 Cr0 Cr0 Cr0 Cr
Inventories6 Cr7 Cr6 Cr5 Cr6 Cr5 Cr9 Cr
Trade receivables8 Cr8 Cr12 Cr12 Cr6 Cr8 Cr10 Cr
Cash & bank0.96 Cr7 Cr5 Cr0.54 Cr2 Cr0.21 Cr0.44 Cr
Other assets3 Cr2 Cr1 Cr7 Cr9 Cr9 Cr6 Cr
Total assets36 Cr41 Cr39 Cr39 Cr39 Cr38 Cr43 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity3 Cr2 Cr4 Cr2 Cr7 Cr-0.04 Cr-0.12 Cr
Cash from investing-0.98 Cr-0.60 Cr0.06 Cr-1 Cr-5 Cr-1 Cr0.50 Cr
Cash from financing-3 Cr5 Cr-6 Cr-3 Cr-0.25 Cr-0.21 Cr-0.16 Cr
Net cash flow-0.29 Cr6 Cr-2 Cr-1 Cr1 Cr-2 Cr0.23 Cr
Free cash flow (OCF − Capex)2 Cr-0.58 Cr4 Cr0.92 Cr4 Cr-2 Cr-3 Cr

Ratios

MetricMar 2017Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %15.5%13.9%14.1%22.5%6.9%9.7%7.6%
ROE %37.0%12.5%10.8%14.7%3.6%6.9%7.5%
Debtor days8761109717479121
Inventory days10993904313888184
Days payable1021191547514263127
Cash conversion cycle9434454069104177
OCF / EBITDA %54.6%28.3%70.9%28.5%223.8%-1.0%-3.7%
OCF / EBITDA % (3 years)———40.4%76.9%60.4%66.8%
Debt / equity5.680.410.130.040.030.030.03
Current ratio—1.401.752.623.114.753.35
Net debt / EBITDA3.88——0.05-0.280.230.21